Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)

<p>Abstract</p> <p>Background</p> <p>Hypertension and type 2 diabetes are common co-morbidities. Preliminary studies suggest that thiazolidinediones reduce blood pressure (BP). We therefore used ambulatory BP to quantify BP lowering at 6–12 months with rosiglitazone use...

Full description

Bibliographic Details
Main Authors: Zambanini Andrew, Pocock Stuart J, Beck-Nielsen Henning, Hanefeld Markolf, Curtis Paula, Komajda Michel, Jones Nigel P, Gomis Ramon, Home Philip D
Format: Article
Language:English
Published: BMC 2008-04-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/7/1/10

Internet

http://www.cardiab.com/content/7/1/10

Similar Items